Click the link below to view our SEDAR filings.
Click the link below to view our archived webinars.
Large Addressable Global Markets
With NO efficient clinical solutions (unmet medical needs)
In the early diagnosis of sepsis and treatment of biofilm Infections
Extensive Intellectual Property
Portfolio of both Diagnostics and Therapeutics
Near-term Revenue Models
With multiple corporate partnership targets
For enhanced shareholder liquidity
Experienced Management Team
With proven track records in med-tech and biopharma